Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Caisson Forms Mfg. Partnership with CordenPharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Caisson Forms Mfg. Partnership with CordenPharma

CordenPharma to serve as a manufacturer and supplier of HEPtune-related materials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Caisson Biotech, a leader in half-life extension and drug delivery, has established a global manufacturing partnership with CordenPharma, a full-service contract development and manufacturing organization (CDMO) manufacturing APIs and drug products through a network of cGMP facilities across Europe and the U.S.

Caisson has demonstrated successful technology transfer and cGMP scale-up with its corporate pharmaceutical partners utilizing its patented heparosan-based half-life extension and drug delivery platform, HEPtune, and will establish similar capabilities with CordenPharma in order to supply licensing partners with HEPtune drug conjugate material. As a manufacturer of the HEPtune technology, CordenPharma will bring experience and expertise in process development and manufacture of complex carbohydrates, including carbohydrate-based polymers and glyco-conjugates, which are an integral component of its peptides, lipids and carbohydrates technology platform offering.

“We are excited to announce a manufacturing relationship with CordenPharma,” said Breca Tracy, vice president and managing director, Caisson. “CordenPharma’s experience manufacturing carbohydrates and polyethylene glycol drug conjugates makes CordenPharma an ideal scale-up manufacturing partner and will accelerate Caisson’s capabilities to fulfill requests for larger quantities of quality material for pre-clinical and clinical studies.”

Mimoun Ayoub, director, global peptides, lipids, carbohydrates and injectables platforms, CordenPharma, said, “We are delighted that Caisson Biotech has selected CordenPharma to serve as a manufacturer and supplier of HEPtune-related materials. This potentially disruptive technology is a natural fit for CordenPharma’s peptides, lipids and carbohydrates platform, and we look forward to supporting Caisson Biotech’s partners as they develop and commercialize novel, life-saving therapeutics.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics